171 related articles for article (PubMed ID: 34309767)
21. SPAG5 upregulation contributes to enhanced c-MYC transcriptional activity via interaction with c-MYC binding protein in triple-negative breast cancer.
Li M; Li A; Zhou S; Lv H; Yang W
J Hematol Oncol; 2019 Feb; 12(1):14. PubMed ID: 30736840
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of CENPU inhibits cervical cancer cell migration and stemness through the FOXM1/Wnt/β-catenin pathway.
Zhang X; Wang M; Zhang Y; Yang J; Duan W
Tissue Cell; 2023 Apr; 81():102009. PubMed ID: 36608638
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway.
Wang CH; Li YH; Tian HL; Bao XX; Wang ZM
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3002-3009. PubMed ID: 29863244
[TBL] [Abstract][Full Text] [Related]
24. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
25. MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A.
Wang N; Zhou Y; Zheng L; Li H
Gynecol Oncol; 2014 Jul; 134(1):129-37. PubMed ID: 24793973
[TBL] [Abstract][Full Text] [Related]
26. CircRNA_069718 promotes cell proliferation and invasion in triple-negative breast cancer by activating Wnt/β-catenin pathway.
Zhang J; Xu HD; Xing XJ; Liang ZT; Xia ZH; Zhao Y
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5315-5322. PubMed ID: 31298383
[TBL] [Abstract][Full Text] [Related]
27. The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer.
Jiang W; He T; Liu S; Zheng Y; Xiang L; Pei X; Wang Z; Yang H
J Hematol Oncol; 2018 Dec; 11(1):139. PubMed ID: 30547809
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway.
Li YM; Li XJ; Yang HL; Zhang YB; Li JC
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4688-4697. PubMed ID: 31210295
[TBL] [Abstract][Full Text] [Related]
29. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
Huang Y; Luo F
IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
[TBL] [Abstract][Full Text] [Related]
30. A feedback circuit comprising EHD1 and 14-3-3ζ sustains β-catenin/c-Myc-mediated aerobic glycolysis and proliferation in non-small cell lung cancer.
Huang J; Tian F; Song Y; Cao M; Yan S; Lan X; Cui Y; Cui Y; Cui Y; Jia D; Cai L; Xing Y; Wang X
Cancer Lett; 2021 Nov; 520():12-25. PubMed ID: 34217785
[TBL] [Abstract][Full Text] [Related]
31. MiR-4524b-5p/WTX/β-catenin axis functions as a regulator of metastasis in cervical cancer.
Li T; Zhou W; Li Y; Gan Y; Peng Y; Xiao Q; Ouyang C; Wu A; Zhang S; Liu J; Fan L; Han D; Wei Y; Shu G; Yin G
PLoS One; 2019; 14(4):e0214822. PubMed ID: 30939162
[TBL] [Abstract][Full Text] [Related]
32. SMAR1 inhibits proliferation, EMT and Warburg effect of bladder cancer cells by suppressing the activity of the Wnt/β-catenin signaling pathway.
Bao P; Li P; Zhou X; Zhang H; You S; Xu Z; Wu Q
Cell Cycle; 2023 Jan; 22(2):229-241. PubMed ID: 35980125
[TBL] [Abstract][Full Text] [Related]
33. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
34. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
Chen Q; Zheng PS; Yang WT
Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
[TBL] [Abstract][Full Text] [Related]
35. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression.
Yu J; Liu D; Sun X; Yang K; Yao J; Cheng C; Wang C; Zheng J
Cell Death Dis; 2019 Jan; 10(1):26. PubMed ID: 30631044
[TBL] [Abstract][Full Text] [Related]
36. Inhibitor of β-catenin and TCF (ICAT) promotes cervical cancer growth and metastasis by disrupting E-cadherin/β-catenin complex.
Jiang Y; Ren W; Wang W; Xia J; Gou L; Liu M; Wan Q; Zhou L; Weng Y; He T; Zhang Y
Oncol Rep; 2017 Nov; 38(5):2597-2606. PubMed ID: 29048651
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of lncRNA HOTTIP Suppresses the Proliferation, Migration, and Invasion of Oral Tongue Squamous Cell Carcinoma by Regulation of HMGA2-Mediated Wnt/β-Catenin Pathway.
Xiong L; Tang Y; Tang J; Liu Z; Wang X
Cancer Biother Radiopharm; 2020 Nov; 35(9):720-730. PubMed ID: 31910357
[No Abstract] [Full Text] [Related]
38. Study on the effect and mechanism of NFKBIA on cervical cancer progress in vitro and in vivo.
Chen M; Liang X; Liang Z; Zhao L
J Obstet Gynaecol Res; 2021 Nov; 47(11):3931-3942. PubMed ID: 34342105
[TBL] [Abstract][Full Text] [Related]
39. H3K27ac-induced RHOXF2 activates Wnt2/β-catenin pathway by binding to HOXC13 to aggravate the malignant progression of triple negative breast cancer.
Guo M; Wang R; Nie M; Zhang H; Wang C; Song C; Niu S
Cell Signal; 2024 Apr; 120():111196. PubMed ID: 38697448
[TBL] [Abstract][Full Text] [Related]
40. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway.
Li B; Guo X; Li N; Chen Q; Shen J; Huang X; Huang G; Wang F
Cell Oncol (Dordr); 2020 Jun; 43(3):489-503. PubMed ID: 32301035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
